Spring Bank Pharmaceuticals, Inc. 4
4 · Spring Bank Pharmaceuticals, Inc. · Filed Aug 24, 2016
Insider Transaction Report
Form 4
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Purchase
Common Stock
2016-08-24$11.90/sh+1,550$18,445→ 37,300 total - Purchase
Common Stock
2016-08-24$12.00/sh+350$4,200→ 37,750 total - Purchase
Common Stock
2016-08-24$11.99/sh+100$1,199→ 37,400 total